GlycoMira receives $2.8M from the National Institute of Dental and Craniofacial Research (NIH) for oral mucositis drug development.
October 29, 2021
GlycoMira receives $2M from the National Institute of Allergy and Infectious Diseases (NIH) for chronic rhinosinusitis drug development
June 24, 2021
Visit with Dr. Won Yong Lee at the upcoming American Association for Cancer Research Annual Meeting in New Orleans (April 8-13th). He will be presenting GlycoMira’s preclinical findings in head and neck cancer models.